TW282469B - - Google Patents

Info

Publication number
TW282469B
TW282469B TW083104888A TW83104888A TW282469B TW 282469 B TW282469 B TW 282469B TW 083104888 A TW083104888 A TW 083104888A TW 83104888 A TW83104888 A TW 83104888A TW 282469 B TW282469 B TW 282469B
Authority
TW
Taiwan
Prior art keywords
pct
sec
date
pub
date nov
Prior art date
Application number
TW083104888A
Other languages
English (en)
Chinese (zh)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of TW282469B publication Critical patent/TW282469B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
TW083104888A 1993-06-11 1994-05-30 TW282469B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201685 1993-06-11

Publications (1)

Publication Number Publication Date
TW282469B true TW282469B (enExample) 1996-08-01

Family

ID=8213890

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083104888A TW282469B (enExample) 1993-06-11 1994-05-30

Country Status (34)

Country Link
US (1) US5691354A (enExample)
EP (1) EP0701556B1 (enExample)
JP (1) JP3498145B2 (enExample)
KR (1) KR100337984B1 (enExample)
CN (1) CN1039120C (enExample)
AT (1) ATE159254T1 (enExample)
AU (1) AU678841B2 (enExample)
BG (1) BG62968B1 (enExample)
BR (1) BR9406765A (enExample)
CA (1) CA2163018A1 (enExample)
CZ (1) CZ285766B6 (enExample)
DE (1) DE69406284T2 (enExample)
DK (1) DK0701556T3 (enExample)
ES (1) ES2108471T3 (enExample)
FI (1) FI955916L (enExample)
GR (1) GR3025805T3 (enExample)
HU (1) HU221620B1 (enExample)
IL (1) IL109975A (enExample)
LV (1) LV11544B (enExample)
MY (1) MY111222A (enExample)
NO (1) NO305123B1 (enExample)
NZ (1) NZ268575A (enExample)
OA (1) OA10201A (enExample)
PH (1) PH31126A (enExample)
PL (1) PL176775B1 (enExample)
RO (1) RO115523B1 (enExample)
RU (1) RU2122546C1 (enExample)
SG (1) SG48821A1 (enExample)
SI (1) SI9420036A (enExample)
SK (1) SK281175B6 (enExample)
TW (1) TW282469B (enExample)
UA (1) UA41936C2 (enExample)
WO (1) WO1994029305A1 (enExample)
ZA (1) ZA944106B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100365312B1 (ko) * 1996-06-27 2003-03-06 얀센 파마슈티카 엔.브이. N-[4-(헤테로아릴메틸)페닐]헤테로아릴아민
NZ520041A (en) * 2000-01-20 2004-11-26 Eisai Co Ltd Novel piperidine compounds and drugs containing the same
RU2242254C2 (ru) * 2002-11-05 2004-12-20 ГУ Новосибирский научно-исследовательский институт патологии кровообращения им. акад. Е.Н. Мешалкина Способ диагностики аритмий сердца
RU2246895C2 (ru) * 2002-11-05 2005-02-27 ГУ Новосибирский научно-исследовательский институт патологии кровообращения им. акад. Е.Н. Мешалкина МЗ РФ Способ прогнозирования желудочковых аритмий у кардиохирургических больных
RU2261123C2 (ru) * 2003-02-17 2005-09-27 ГУ Новосибирский научно-исследовательский институт патологии кровообращения им. акад. Е.Н. Мешалкина МЗ РФ Способ прогнозирования атриовентрикулярных блокад после радикальной кардиохирургической коррекции пороков сердца у детей раннего возраста
RU2261122C2 (ru) * 2003-02-17 2005-09-27 ГУ Новосибирский научно-исследовательский институт патологии кровообращения им. акад. Е.Н. Мешалкина МЗ РФ Способ определения уровня атриовентрикулярной блокады у больных после хирургической коррекции пороков сердца
RU2261121C2 (ru) * 2003-02-17 2005-09-27 ГУ Новосибирский научно-исследовательский институт патологии кровообращения им. акад. Е.Н. Мешалкина МЗ РФ Способ определения степени зависимости от электрокардиостимулятора
RU2261041C2 (ru) * 2003-04-24 2005-09-27 ГУ Новосибирский научно-исследовательский институт патологии кровообращения им. акад. Е.Н. Мешалкина МЗ РФ Способ прогнозирования пароксизмальной эктопической атриовентрикулярной тахикардии
RU2261124C2 (ru) * 2003-04-24 2005-09-27 ГУ Новосибирский научно-исследовательский институт патологии кровообращения им. акад. Е.Н. Мешалкина МЗ РФ Способ оценки электрических свойств рабочего миокарда

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ16485A3 (cs) * 1984-01-09 1993-12-15 Janssen Pharmaceutica Nv Způsob přípravy 4-/(bicyklyl heterocyklyl) methyl a hetero/-piperidinů
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US5010198A (en) * 1984-12-03 1991-04-23 Janssen Pharmaceutica N.V. Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
FI955916A7 (fi) 1995-12-08
EP0701556A1 (en) 1996-03-20
PH31126A (en) 1998-02-23
CA2163018A1 (en) 1994-12-22
IL109975A0 (en) 1994-10-07
SK281175B6 (sk) 2000-12-11
PL311965A1 (en) 1996-03-18
NO954801L (no) 1995-11-27
NO305123B1 (no) 1999-04-06
UA41936C2 (uk) 2001-10-15
OA10201A (en) 1996-12-18
CN1039120C (zh) 1998-07-15
EP0701556B1 (en) 1997-10-15
ZA944106B (en) 1995-12-11
LV11544B (en) 1997-08-20
FI955916A0 (fi) 1995-12-08
AU678841B2 (en) 1997-06-12
CZ319295A3 (en) 1996-03-13
ATE159254T1 (de) 1997-11-15
NZ268575A (en) 1996-08-27
WO1994029305A1 (en) 1994-12-22
SI9420036A (en) 1996-10-31
HU9501971D0 (en) 1995-09-28
JP3498145B2 (ja) 2004-02-16
NO954801D0 (no) 1995-11-27
DE69406284D1 (de) 1997-11-20
SK154495A3 (en) 1996-06-05
AU7183894A (en) 1995-01-03
DE69406284T2 (de) 1998-02-19
RO115523B1 (ro) 2000-03-30
BG100210A (bg) 1996-07-31
PL176775B1 (pl) 1999-07-30
IL109975A (en) 1999-04-11
JPH08511014A (ja) 1996-11-19
DK0701556T3 (da) 1998-01-26
SG48821A1 (en) 1998-05-18
ES2108471T3 (es) 1997-12-16
RU2122546C1 (ru) 1998-11-27
HUT73679A (en) 1996-09-30
CZ285766B6 (cs) 1999-11-17
FI955916L (fi) 1995-12-08
LV11544A (lv) 1996-10-20
US5691354A (en) 1997-11-25
MY111222A (en) 1999-09-30
GR3025805T3 (en) 1998-03-31
BR9406765A (pt) 1996-02-21
KR100337984B1 (ko) 2002-10-25
HU221620B1 (hu) 2002-12-28
CN1125443A (zh) 1996-06-26
BG62968B1 (bg) 2000-12-29

Similar Documents

Publication Publication Date Title
ZA948670B (en) New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions
ZW8594A1 (en) Substituted azadioxacycbalkenes
TW283716B (enExample)
TW282469B (enExample)
AU4623396A (en) 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
GB9424766D0 (en) Pharmaceutical composition
DK0866791T3 (da) Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
TW367326B (en) Pyrimidine derivative, process for the preparation thereof and a pharmaceutical composition containing same
IL114968A0 (en) 1,4-dihydropyridine compounds
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
HU9601381D0 (en) Substituted aminoalkylaminopyridines
AU2002210537A1 (en) (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
WO2003007922A3 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten
CA2152280A1 (fr) Utilisation du riluzole comme radiorestaurateur
AU5668698A (en) Method for preparing a tetrahydropyridin derivative
IT1262990B (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti,in particolare antagonisti dell'lh-rh